EphB4 gene polymorphism and protein expression in non-small-cell lung cancer

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 405-408

  Zheng, Ming Feng ^a   Ji, Yong ^a   Wu, Xiao Bo ^a   Ye, Shu Gao ^a   Chen, Jing Yu ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

EphB4; Immunohistochemistry; Non small cell lung cancer; Polymerase chain reaction restriction fragment length polymorphism; Single nucleotide polymorphism

Indexed keywords

EPHRIN RECEPTOR B4;

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR RECURRENCE;

ADULT; AGED; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPHB4; SEVERITY OF ILLNESS INDEX;

EID: 84863458095     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.936     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
2. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007. (Pubitemid 46148091)
3. Yang L, Parkin DM, Li LD, Chen YD and Bray F: Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90: 2157-2166, 2004. (Pubitemid 38869723)
4. Murray T, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008. (Pubitemid 351521864)
5. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
6. Pasquale EB: Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6: 462-475, 2005.
7. Erber R, Eichelsbacher U, Powajbo V, et al: EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J 25: 628-641, 2006. (Pubitemid 43237669)
8. Kumar SR, Singh J, Xia G, et al: Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169: 279-293, 2006.
9. Shimosato Y: Histological typing of lung and pleural tumors (3rd edition, 1999): malignant epithelial tumors. Nihon Rinsho 60: 123-131, 2002.
10. Shen LQ, Wang XC, Zhao J, Di HZ and Zhuang ZX: Association between Eph4 gene polymorphism and non-small cell lung cancer. Chin J Clin Oncol 31: 778-779, 2009.
11. 2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31: 321-328, 1993.
12. Yarden Y and Ullrich A: Growth factor receptor tyrosine kinases. Annu Rev Biochem 57: 443-478, 1988.
13. Himanen JP and Nikolov DB: Eph signaling: a structural view. Trends Neurosci 26: 46-51, 2003.
14. Wang HU, Chen ZF and Anderson DJ: Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753, 1998. (Pubitemid 28257581)
15. Cheng N, Brantley DM and Chen J: The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13: 75-85, 2002. (Pubitemid 34436963)
16. Stephenson SA, Slomka S, Douglas EL, Hewett PJ and Hardingham JE: Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. BMC Mol Biol 2: 15-17, 2001.
17. Takai N, Miyazaki T, Fujisawa K, Nasu K and Miyakawa I: Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol Rep 8: 567-573, 2001. (Pubitemid 33758456)
18. Nowotny P, Kwon JM and Goate AM: SNP analysis to dissect human traits. Curr Opin Neurobiol 11: 637-641, 2001. (Pubitemid 32938298)